TULP4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.346390E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.296180E-02
Normal-vs-Stage2
9.837400E-03
Normal-vs-Stage3
1.474280E-02
Normal-vs-Stage4
6.730300E-02
Stage1-vs-Stage2
7.749800E-01
Stage1-vs-Stage3
2.431600E-01
Stage1-vs-Stage4
5.840200E-01
Stage2-vs-Stage3
1.506640E-01
Stage2-vs-Stage4
7.671200E-01
Stage3-vs-Stage4
1.812230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.093870E-02
Normal-vs-AfricanAmerican
1.907630E-01
Normal-vs-Asian
9.822900E-03
Caucasian-vs-AfricanAmerican
6.709900E-02
Caucasian-vs-Asian
2.366200E-01
AfricanAmerican-vs-Asian
2.467800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.591500E-02
Normal-vs-Female
6.523300E-03
Male-vs-Female
8.488800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.423600E-02
Normal-vs-Age(41-60Yrs)
4.879700E-02
Normal-vs-Age(61-80Yrs)
1.015790E-02
Normal-vs-Age(81-100Yrs)
4.383200E-04
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.836200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.742800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.353400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.761300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.286120E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.789000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.283610E-02
Normal-vs-Daily Drinker
3.339700E-03
Normal-vs-Weekly Drinker
1.979490E-03
Normal-vs-Occasional Drinker
1.541810E-01
Normal-vs-Social Drinker
6.747600E-02
Non Drinker-vs-Daily Drinker
5.594600E-01
Non Drinker-vs-Weekly Drinker
5.752400E-01
Non Drinker-vs-Occasional Drinker
1.965230E-01
Non Drinker-vs-Social Drinker
5.098200E-01
Daily Drinker-vs-Weekly Drinker
9.648600E-01
Daily Drinker-vs-Occasional Drinker
8.926000E-02
Daily Drinker-vs-Social Drinker
2.598200E-01
Weekly Drinker-vs-Occasional Drinker
1.241800E-01
Weekly Drinker-vs-Social Drinker
2.853000E-01
Occasional Drinker-vs-Social Drinker
6.145400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.767900E-02
Normal-vs-Grade 2
3.972400E-02
Normal-vs-Grade 3
5.183900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.707200E-01
Grade 1-vs-Grade 3
4.674800E-01
Grade 1-vs-Grade 4
7.767900E-02
Grade 2-vs-Grade 3
9.612800E-01
Grade 2-vs-Grade 4
3.972400E-02
Grade 3-vs-Grade 4
5.183900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.252080E-02
Normal-vs-NonDiabetic
9.719100E-03
Diabetic-vs-NonDiabetic
4.375600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.316290E-02
Normal-vs-NoPancreatitis
1.108300E-02
Pancreatitis-vs-NoPancreatitis
9.735000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.119800E-02
Normal-vs-N1
1.161800E-02
N0-vs-N1
8.756600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.304300E-02
Normal-vs-TP53-NonMutant
9.202200E-02
TP53-Mutant-vs-TP53-NonMutant
1.298630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
